Latest Tuberculosis treatment Stories
STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/
Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine,
IBM's Big Data analytics to help crack the code of the tuberculosis genome and uncover new diagnosis and treatment approaches DURBAN, South Africa, March 24, 2014 /PRNewswire/ -- On
Global partnerships and significant medical research are a big part of this year’s World Tuberculosis Day. Celebrated each year on March 24, World TB Day is a marked as a time to bring attention to the threat of tuberculosis...
Thousands receive treatment prior to coming to the United States ATLANTA, March 20, 2014 /PRNewswire-USNewswire/ -- Updated CDC recommendations for overseas tuberculosis (TB) screening
BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent
MOSCOW, February 13, 2014 /PRNewswire/ -- Russian and Korean biotech companies Infectex Ltd. [http://www.infectex.ru/?ln=en ] and Qurient Ltd.
Multi-year grant brings together non-profits, government, academia and the pharmaceutical industry to study pressing public health challenge TUCSON, Ariz., Feb.
Aim to Improve Care for HIV Patients in Irkutsk, Halt Growing Health Threat Charlottesville, VA (PRWEB) January 28, 2014 Researchers at the University
A major trial aiming to cut the rate of tuberculosis (TB) among South Africa's gold miners did not reduce the number of cases or deaths from the disease.
- A political dynamiter.